MedPath

一力制药(罗定)有限公司

Ownership
-
Established
2013-03-21
Employees
-
Market Cap
-
Website
http://www.ylldzyc.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

脑心舒口服液

Approval Number
国药准字Z20188048
Approval Date
Dec 18, 2023
NMPA

Omeprazole Enteric Capsules

Product Name
奥美拉唑肠溶胶囊
Approval Number
国药准字H20073711
Approval Date
Jun 6, 2023
NMPA

Febuxostat Tablets

Product Name
非布司他片
Approval Number
国药准字H20223640
Approval Date
Aug 30, 2022
NMPA

复方感冒灵片

Approval Number
国药准字Z44023210
Approval Date
Oct 27, 2020
NMPA

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H44021124
Approval Date
Sep 2, 2020
NMPA

Dipyridamole Tablets

Product Name
双嘧达莫片
Approval Number
国药准字H44021132
Approval Date
Aug 13, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H44021126
Approval Date
Aug 13, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H44021136
Approval Date
Aug 12, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H44021125
Approval Date
Aug 12, 2020
NMPA

Compound Aminopyrine Phenacetin Tablets

Product Name
去痛片
Approval Number
国药准字H44021131
Approval Date
Aug 12, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.